Back to search

Article

Metabolic medications modify prostate cancer progression through exosome reprogramming

2025-12-10

Abstract excerpt

Among prostate cancer patients, co-morbid Type 2 Diabetes (T2D) is associated with faster progression to biochemical recurrence and increased risk of mortality. Previous work from our lab provides evidence that exosomes purified from media of insulin resistant adipocytes or T2D patient plasma likely drives these outcomes by delivering miRNAs that exacerbate tumor aggressiveness in several breast and prostate cance...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6f40ecb5-fb8d-5899-88c5-72dd93983d2d
DOI
10.64898/2025.12.07.692844
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Metabolic medications modify prostate cancer progression through exosome reprogrammingDOI 10.64898/2025.12.07.692844
Select a neighboring publication to make it the new centre.